Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Post Market Clinical Follow-up Study of the Avenir® Cemented Hip Stem

NCT03396224 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03396224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Post Market Clinical Follow-up Study of the Avenir® Cemented Hip Stem
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Active, not recruiting
Start date
November 18, 2015
Completion date
November 30, 2030
Enrollment
100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congenital hip dysplasia, femoral head necrosis, femoral neck fractures, osteotomies, post-traumatic osteoarthritis of hip, primary osteoarthritis, sequelae from previous hip surgery